MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • Noticias
  • Store
  • Corredores
  • Descargar
  • Calendario económico
  • Señales Comerciales
  • WebTerminal
  • English English
  • Русский Русский
  • 中文 中文
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Soleno Therapeutics, Inc. Common Stock

SLNO

#1669
Soleno Therapeutics, Inc. Common Stock
39.07
+5.51%
Sector:
Básica:
Profit Currency:
Rango diario
39.07
39.07
Rango anual
32.84
90.32
Cambio diario
+5.51%
Monthly Change
-9.20%
6 month change
-42.34%
Cambio anual
-13.27%
Cierres anteriores
37.03
Open
39.07
Bid
Ask
Low
39.07
High
39.07
Volumen
143
  1. Markets
  2. Acciones
  3. Atención Sanitaria
  4. SLNO
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 202020212022202320242025 TTM

Noticias

Investing Investing
SLNO
anteayer, 14:32
Las acciones de Soleno Therapeutics alcanzan mínimos de 52 semanas en 36,01 dólares
Investing Investing
SLNO
anteayer, 14:31
Soleno Therapeutics stock hits 52-week low at 36.01 USD
Investing Investing
SLNO
anteayer, 13:22
Soleno Therapeutics nombra a Jennifer Fulk como directora financiera
Investing Investing
SLNO
anteayer, 13:21
Soleno Therapeutics names Jennifer Fulk as CFO
Investing Investing
SLNO
2026.02.25
Soleno Therapeutics earnings beat by $0.19, revenue topped estimates
Investing Investing
SLNO
2026.02.25
Soleno Therapeutics enfrenta prueba de resultados mientras se examinan métricas de lanzamiento
Investing Investing
SLNO
2026.02.25
Soleno Therapeutics faces earnings test as launch metrics scrutinized
Investing Investing
SLNO
2026.02.12
Las acciones de Soleno Therapeutics caen a mínimos de 52 semanas a 37,95 dólares
Investing Investing
SLNO
2026.02.12
Soleno Therapeutics stock hits 52-week low at 37.95 USD
Zacks Zacks
ALKS RARE SLNO
2026.02.02
Ultragenyx Pharmaceutical Resubmits UX111 BLA for Sanfilippo Syndrome
Zacks Zacks
SLNO
2026.02.02
Down 18.3% in 4 Weeks, Here's Why Soleno Therapeutics (SLNO) Looks Ripe for a Turnaround
Zacks Zacks
ALKS SMMT SLNO
2026.01.30
FDA Accepts SMMT's Application Seeking Approval for NSCLC Drug

Markets

  • Acciones
  • Divisas
  • Criptomonedas
  • Metales
  • Mercancías

Charts & Ideas

  • Ideas comerciales
  • Ideas ilustrativas
  • Gráfico

MQL5 Community

  • Market
  • Señales
  • Foro
  • Artículos
  • CodeBase

Noticias

  • Acciones
  • Divisas
  • Criptomonedas
  • Metales
  • Mercancías

Corredores

  • Todos los brókeres
  • Fórex
  • Acciones
  • Metales
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Información y contacto Legal
Copyright 2000-2026, MetaQuotes Ltd